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Increased recognition of the role of inflammation in acute and chronic dilated cardiomyop-
athy has revived an interest in noninvasive imaging for detection of myocarditis. Diagnostic
strategies that are based on molecular imaging promise to further advance our understanding
and improve diagnostic precision. This article reviews the strengths and limitations of
common clinical tests used for the diagnosis of myocarditis, with a focus on the emerging role
of cardiovascular magnetic resonance imaging. Novel imaging modalities that are currently
in preclinical development are discussed with recommendations for future clinical
research. (J Am Coll Cardiol 2006;48:2085–93) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.08.017Cardiology Foundation
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myocarditis may be diagnosed by clinical, pathological, or a
ombination of diagnostic criteria. The lack of precision in
iagnostic criteria and heterogeneity of presentations (1) has
ed to complex and confusing reports. Despite a lengthy list
f potential causes, the most common etiology in North
merica and Europe remains a viral infection with associ-
ted myocardial inflammation (2). Advances in our under-
tanding of persistent viral infection and the subtleties of
mmune activation in the past decade have led to revised
athological criteria, novel diagnostic tests, and new thera-
eutic strategies (2), at least for the most common forms of
yocarditis. In light of these recent advances, we review the
ajor features of viral and immune-mediated cardiomyop-
thy because they represent diagnostic targets for noninva-
ive imaging.
Myocardial inflammation per se is a nonspecific response
o various triggers such as viral or bacterial infection,
ardiotoxic agents, catecholamines, infarction, or mechani-
al injury. Whereas most of these etiologic factors may
lready be evident from the patient’s history, viral infection
ay come with nonspecific symptoms or without any
ymptoms at all. Viral myocarditis, however, is more fre-
uent than is clinically obvious. Thus, we focus our review
n viral myocarditis.
Several viruses have been associated with myocarditis
ased on the detection of viral genome in cardiac tissue of
atients. These cardiotropic viruses include Coxsackie B
irus, non-Coxsackie enteroviruses, certain strains of ade-
ovirus, parvovirus B19, and Epstein-Barr virus (3). Im-
une activation follows acute viral infection with activation
f T and B cells, antibody production, cytokine release, and
omplement activation (2). However, our knowledge of viral
ardiomyopathy is limited in part because the mechanisms
From the *Cardiovascular Department, Mayo Clinic, Rochester, Minnesota;
Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts; and
he ‡Stephenson CMR Centre, University of Calgary, Calgary, Alberta, Canada.c
Manuscript received March 1, 2006; revised manuscript received July 5, 2006,
ccepted July 5, 2006.esponsible for viral infection, details of viral life cycle, and
haracter of the immune response are only well known for
ertain strains of CVB. Persistent inflammation and/or
ersistent viral infection may lead to dilated cardiomyopathy
DCM) (4,5). Apoptosis, which commonly accompanies
cute and chronic viral myocarditis (5), may also provide an
pportunity for novel imaging.
S THERE A NEED FOR
ONINVASIVE IMAGING IN MYOCARDITIS?
he need for accurate diagnostic imaging in myocarditis
rises from the lack of specificity and sensitivity of routine
ardiac tests. Myocarditis may present with a wide spectrum
f symptoms, including chest pain, recent onset of heart
ailure from systolic or diastolic dysfunction, atrial or ven-
ricular arrhythmias, cardiogenic shock, or even sudden
eath (1,2).
This diversity of clinical manifestations has made the true
ncidence of myocarditis difficult to determine. Myocarditis
s not uncommon and has been found in 1% to 9% of
outine autopsy cases, and in 5% to 12% of those performed
or unexplained sudden cardiac death in young individuals
6,7). Further, it has been identified as a cause of DCM in
% of cases in 1 large prospective series (8).
Endomyocardial biopsy (EMB) is still considered by
any clinicians to be the gold standard for diagnosing
yocarditis. The 1987 Dallas criteria require lymphocytic
nfiltration associated with myocyte injury in the absence of
schemia (9). These criteria are highly specific but have only
10% to 22% sensitivity for myocarditis (10,11). The lack of
recision of the Dallas criteria arise from sampling error
aused by patchy involvement of the myocardium (2) and
igh interobserver variability in interpretation. To diagnose
yocarditis with an 80% sensitivity, an estimated 17 right
entricular biopsy specimens (11) are needed. Autopsy and
agnetic resonance imaging studies have shown that myo-arditis more frequently affects the left ventricular (LV) free
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Noninvasive Imaging in Myocarditis November 21, 2006:2085–93all than the septum (12–14). Thus, the risks and low
ensitivity of EMB limit its current diagnostic use in acute
CM to a research tool or to exclude giant cell myocarditis.
ore and more experts have called for abandoning the use
f the Dallas criteria (15). In chronic DCM, EMB remains
he only way to confirm the presence of the viral genome
nd guide treatment for persistent viral infection. Other
athological diagnostic criteria for myocarditis, including
he expression of class I and II human lymphocyte antigen
n cardiac myocytes (16), may identify a subset of patients
ith chronic myocarditis who have a response to azathio-
rine and prednisone (17). The usefulness of these novel
iagnostic tests will also be limited by sampling error and
he risks of the EMB.
CHOCARDIOGRAPHY
he most common echocardiographic features of acute
yocarditis are quite nonspecific (18). Pinamonti et al. (18)
eported echocardiographic patterns of dilated, hypertro-
hic, restrictive, and ischemic cardiomyopathy in 41 pa-
ients with histologically proven myocarditis. Segmental
all motion abnormalities (hypokinesia, akinesia, and dys-
inesia) that can simulate acute myocardial infarction
AMI) are quite common (18,19). The LV is typically
ormal-sized or mildly dilated in patients with acute heart
ailure. Advances in the detection of subtle diastolic dys-
unction, regional strain rates, and tissue characterization
ave increased the diagnostic role of echocardiography. In
arly stages, focal inflammation leads to local cell necrosis
nd tissue edema, often before global LV dilatation or
ysfunction are evident. Increased sphericity and LV vol-
me occur in acute, active myocarditis (20). Echocardiog-
aphy is useful for detecting LV thrombus, transient LV
neurysm, right ventricular involvement, and pericardial
ffusion (18,19).
Transient increases in LV wall thickness have been
eported (21). Hiramitsu et al. (21) investigated 25 patients
ith histologically proven myocarditis. The interventricular
eptum and LV wall thickness decreased from 14.3  3.7
m and 13.3 2.4 mm in the acute phase to 9.7 1.7 mm
Abbreviations and Acronyms
AM  antimyosin
AMI  acute myocardial infarction
CMR  cardiac magnetic resonance
DCM  dilated cardiomyopathy
EMB  endomyocardial biopsy
FM  fulminant myocarditis
H/L  heart-to-lung ratio
LE  late enhancement
LGE  late gadolinium enhancement
LV  left ventricle/ventricular
RVSF  right ventricular systolic function
TD  tissue Doppler
USPIO  ultrasmall superparamagnetic iron oxidep  0.001) and 10.2  1.7 mm (p  0.0001) in the aonvalescent phase. In the acute phase, an increase in wall
hickness as a measure of edema was present in 88.0% of
ases compared with only 28% in the convalescent phase
p  0.0001). In some cases, myocarditis can simulate
ymmetrical (21,22) or asymmetrical (23,24) hypertrophic
ardiomyopathy. A relatively thicker posterior wall (ratio of
nd-diastolic posterior wall thickness to cavity dimensions
0.17 mm) has been associated with better prognosis and
ecovery in children presenting with dilated cardiomyopathy
nd myocarditis (25).
The acoustic properties of the myocardium can be defined
sing ultrasonic backscatter and infer the physical state of
ardiac muscle. The myocardial density and elasticity are
nfluenced by the extent of edema and cell infiltration. The
yclic variation of integrated backscatter can assess myocar-
ial viability (26), cardiomyopathies (27), and cardiac allo-
raft rejection (28). Lieback et al. (29) described texture
nalysis in 106 patients suspected of having myocarditis.
he mean gray value (average brightness) was significantly
igher in cases of histologic myocarditis compared with
ontrol subjects. The diagnostic accuracy, however, was not
eported, and ultrasonic tissue characterization could not
ifferentiate between idiopathic DCM and acute myocardi-
is. Nonetheless, several case reports suggest that an increase
n brightness, heterogeneity, and contrast may be useful to
onfirm acute myocarditis (30,31).
Fulminant myocarditis (FM) has a more rapid onset of
llness with severe hemodynamic compromise, but remark-
bly good long-term survival (1). Felker et al. (32) showed
hat FM can be distinguished from acute myocarditis by
chocardiographic criteria. Patients with FM had near-
ormal LV diastolic dimensions (5.3  0.9 cm) with
ncreased septal thickness (1.2  0.2 cm) at presentation,
hereas those with acute myocarditis had increased diastolic
imensions but normal septal thickness. After 6 months,
atients with FM had significant improvement in fractional
hortening (30  8%) compared with patients with acute
yocarditis (19  7%, p  0.01).
Right ventricular function is an independent predictor of
eath or cardiac transplantation in acute myocarditis.
endes et al. (33) assessed right ventricular systolic func-
ion (RVSF) by descent of the right ventricular base (34).
nitial LV ejection fraction was significantly lower in myo-
arditis patients with depressed right ventricular function
27.5 4.9% vs. 47.5 6.3% for normal RVSF, p 0.01).
he likelihood of death or need for cardiac transplantation was
lso significantly greater in patients with abnormal RVSF (RV
escent 1.7 cm) than in patients with normal RVSF (p 
.03). Sixty percent of patients with abnormal RVSF died or
equired transplantation, compared with none of the pa-
ients with normal RVSF at 24 months. Multivariate
nalysis showed that right ventricular dysfunction as quan-
itated by right ventricular descent was the most powerful
redictor of outcome.
Naqvi et al. (35) showed that contractile reserve asssessed by dobutamine echocardiography has prognostic
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November 21, 2006:2085–93 Noninvasive Imaging in Myocarditisalue in 22 patients with new-onset DCM. Baseline vari-
bles that were significantly predictive of follow-up LV
jection fraction were deceleration time (r  0.69, p 
.0006), wall motion score index (r  0.63, p  0.002),
V mass (r  0.56, p  0.008), and LV ejection fraction
fter dobutamine (r  0.84, p  0.0001). These data
uggest that dobutamine echocardiography may be useful in
he assessment of patients with recently diagnosed DCM,
ome of which may be caused by myocarditis.
Tissue Doppler (TD) has also been used to assess acute
yocarditis. Urhausen et al. (36) reported a case of biopsy-
roven myocarditis in which no abnormalities were shown
sing 2-dimensional echocardiography and color and
ulsed-wave Doppler. However, a net loss of systolic re-
ional wall velocity was evident by cardiac TD. In the same
ear, Adsett et al. (22) reported a case of biopsy-proven
osinophilic myocarditis. The TD parameters were mea-
ured and showed systolic and diastolic abnormalities. Color
-mode TD of the LV posterior wall showed a reduction
f both mean myocardial velocities and myocardial velocity
radient in systole and diastole TD. The role of TD in acute
yocarditis remains an area of active investigation.
ALLIUM-67 IMAGING
allium-67 is considered an excellent imaging agent for
hronic inflammation and has been used for diagnosing
everal autoimmune chronic inflammatory conditions. Clin-
cal and experimental studies have indicated the usefulness
f gallium-67 citrate scintigraphy in detecting myocarditis
37). O’Connell et al. (38) compared gallium-67 with EMB
n 68 DCM patients. Only 8% of the study population had
istologic evidence of myocarditis; 87% of these patients
ere positive by gallium-67 scanning. Only a 1.8% inci-
ence of myocarditis was detected histologically in the
allium-67 negative cohort. Subsequently, Matsura et al.
39) showed the usefulness of gallium-67 imaging, espe-
ially in identifying myocarditis in 46 consecutive children
n the acute phase of Kawasaki disease. The use of gallium
maging has diminished over time mainly because of a lack
f specificity.
NDIUM-111 ANTIMYOSIN ANTIBODY
haw et al. (40) developed a noninvasive imaging test to
etect myocyte necrosis by using a monoclonal antibody
irected against human cardiac myosin. Indium-111 radio-
abeled antimyosin (AM) antibodies have been shown to
etect myocardial necrosis in animal models (41) and
uman myocarditis (42). Yasuda et al. (43) first reported the
se of indium-111 AM imaging in 28 patients clinically
uspected of having myocarditis (Fig. 1). Antimyosin scans
ere positive in 61% of the study group, 9 of whom had
vidence of myocarditis on EMB, and negative in 100%
f patients without evidence of myocarditis by biopsy.
hus, the sensitivity of AM imaging was 100% and itspecificity was 58%. aCarrio et al. (44) refined the technique by using the
eart-to-lung (H/L) ratio, a semiquantitative approach for
valuating AM uptake in detecting myocyte damage. A
ignificant difference in H/L ratio between normal subjects
1.46  0.04) and myocarditis patients (2.0  0.5) (p 
.001) was shown. Narula et al. (45) confirmed the utility of
he H/L ratio in the diagnosis of myocarditis.
Dec et al. (46) examined the sensitivity, specificity, and
redictive value of indium-111 AM cardiac imaging in 82
atients presenting with clinically suspected myocarditis.
sing planar and single-photon emission computed tomog-
aphy cardiac imaging, the sensitivity of AM imaging was
3%, its specificity was 53%, and the negative predictive
alue was 92%. Narula et al. (45) also compared scinti-
raphic results with histological evaluation and found a high
ensitivity for the detection of myocarditis (91% to 100%)
nd a high negative predictive value (93% to 100%). The
pecificity (31% to 44%) and positive predictive value (28%
o 33%) were again found to be low. A positive AM scan
redicted a significantly greater likelihood than myocardial
iopsy of a subsequent improvement in ejection fraction in
cute DCM patients.
Indium-111 AM imaging has also been used to diagnose
nd follow up the natural history of myocardial damage in
dult patients with idiopathic, alcoholic, and inflammatory
ardiomyopathies (47), and in children with cardiomyopa-
hy (48). In a study of 10 patients with acute myocarditis,
/L ratios normalized (from 2.2 to 1.6) within 6 months
n all patients (49). The intensity of AM uptake was the
ajor determinant of survival in children, with a relative risk
f 18 (95% confidence interval 1.34 to 242; p 0.027) (48).
ne common finding across many studies is that a substan-
ial percentage of patients with DCM are positive for AM
cintigraphy although their EMB did not show histological
vidence of myocarditis (50).
Thus, indium-111 AM antibody imaging seems to be a
seful noninvasive screening method for diagnosing myo-
arditis with a high sensitivity (91% to 100%) and a high
egative predictive value (93% to 100%) (45). It can be used
o identify localized as well as diffuse myocardial damage.
imitations to this technique include its current limited
vailability in the U.S., radiation exposure, and 48-hour
elays in obtaining imaging after injection to prevent blood
ool effect.
ARDIAC MAGNETIC RESONANCE (CMR) IMAGING
agliardi et al. (51) published the first case series on the use
f CMR for the noninvasive diagnosis of acute myocarditis
n 11 infants and children. Compared with EMB (Dallas
riteria), T2-weighted spin echo CMR sequences were
ound to have a 100% specificity and 100% sensitivity. This
mall study was followed by a second report by Gagliardi
t al. (52) on 75 consecutive pediatric patients with acute
ymptomatic heart failure; EMB identified 51 patients with
cute myocarditis and 24 with idiopathic DCM. Using
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Noninvasive Imaging in Myocarditis November 21, 2006:2085–93MB as the diagnostic standard, T2-weighted CMR se-
uences achieved a sensitivity of 100% and a specificity of
0%. The same group reported preliminary data on the 53
hildren affected by myocarditis who had serial EMB and
MR studies every 6 months for a 2-year follow-up period.
he sensitivity and specificity of CMR remained high
uring the subsequent evolution of the disease (52).
The use of ECG-triggered gadolinium-enhanced T1-
eighted images to serially image the natural history of
cute myocarditis was reported by Friedrich et al. (13). A
otal of 44 consecutive patients with suspected acute myo-
arditis based on clinical and laboratory features underwent
erial contrast media–enhanced CMR to document the
istribution of contrast uptake over a 3-month period.
cute myocarditis was associated with focal contrast en-
ancement on day 2 (Fig. 2), which evolved by day 7 into
iffuse myocardial involvement that persisted until 2 to 4
eeks (Fig. 3). By day 84, the average myocardial contrast
ignal had returned to that of the controls.
Roditi et al. (53) assessed a combination of techniques,
ine magnetic resonance angiography and T1 spin echo
efore and after gadolinium enhancement, in 12 patients
ith suspected acute myocarditis and 8 with chronic car-
iomyopathy. Ten of 12 patients in the myocarditis group
howed focal myocardial enhancement with associated re-
igure 1. Antimyosin cardiac imaging for detection of acute myocarditis. A
he anterior planar (A) and in all coronal tomographic reconstructions (B
eprinted with permission of G. W. Dec, MD.ional wall motion abnormalities (hypokinesis, akinesis, or 9yskinesis). The control group showed minimal focal en-
ancement. This study suggested that a combination of
MR findings may provide greater diagnostic accuracy for
he diagnosis of acute myocarditis than regional wall motion
r focal myocardial enhancement alone.
Laissy et al. (54) prospectively compared the value of
ifferent CMR modalities for the evaluation of cardiac and
keletal muscle enhancement in patients with acute myo-
arditis. A comprehensive imaging approach was used
ncluding axial T2-weighted sequences, precontrast and
ostcontrast ECG-gated T1-weighted sequences, cine-
MR, and serial dynamic turbo fast low-angle shot acqui-
itions. Twenty patients with myocarditis and 7 age- and
ender-matched control subjects were studied. Subtraction
adolinium-enhanced T1-weighted CMR accurately iden-
ified myocardial involvement with 100% sensitivity and
00% specificity. Furthermore, a 45% myocardial en-
ancement score strongly supported the diagnosis of myo-
arditis. Turbo fast low-angle shot imaging displayed
reater myocardial enhancement (p  0.0001) and showed
nexpected enhancement of skeletal muscle in the early and
ate stages of myocarditis (p  0.0001).
Two studies suggest that CMR may differentiate ischemic
rom nonischemic cardiomyopathy (55,56). McCrohon et al.
55) performed gadolinium late enhancement (LE) CMR in
itive antimyosin image shows diffuse uptake in the cardiac region on both
rows). Biopsy confirmed multifocal lymphocytic myocarditis. L  liver.pos0 patients with heart failure and LV systolic dysfunction.
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November 21, 2006:2085–93 Noninvasive Imaging in Myocarditisll patients (100%) with ischemic cardiomyopathy (n 27)
ad either subendocardial or transmural enhancement. In
ontrast, the DCM group (n  63) had 3 distinct myocar-
ial patterns: no enhancement (59%), patchy or longitudinal
triae of midwall enhancement consistent with fibrosis
28%), and myocardial enhancement indistinguishable from
he patients with CAD (13%). These data suggest that
adolinium CMR accurately can exclude the presence of LV
ysfunction related to CAD in most heart failure patients.
unold et al. (56) subsequently identified different patterns
f myocardial LE. In 402 patients with documented myo-
ardial infarction, the subendocardial layer showed LE. In
he nonischemic group (n  19), the subendocardial layer
as not involved in patients with myocarditis, DCM, or
ypertrophic cardiomyopathy; LE in this group was local-
zed to the epicardial or midmyocardial wall. Thus, the
attern and localization of LE in contrast-enhanced CMR
an often help in distinguishing primary myocardial from
igure 2. Short-axis cardiac magnetic resonance images of the same anat
Upper row, left) Steady-state free precession images in diastole (left) an
ffusion. (Upper row, right) Triple-inversion-recovery prepared T2-weig
nterolateral, and inferior segments with predominant subepicardial involv
fter (right) application of gadolinium. Note the diffuse signal intensity inc
ow, right) T1-weighted inversion-recovery prepared gradient echo image
igh signal intensity (late enhancement), predominantly involving subepica
s pathology.schemic disease. sIn 2004, Mahrholdt et al. (57) used an inversion-recovery
repared gradient echo sequence, which is widely used for
MR of myocardial infarcts. Of 32 patients with suspected
yocarditis, 88% showed patchy, epicardial, and lateral wall
ontrast enhancement (Fig. 4). The CMR-guided EMB
rom the regions of contrast enhancement showed active
yocarditis in 19 of 21 patients. Active myocarditis was
ound in 1 of 11 patients in whom EMB was performed in
egions without contrast enhancement. At 3 months, the
rea of LV contrast enhancement decreased from 9  11%
o 3  4%. This decrease was associated with an improve-
ent in the LV ejection fraction from 47  19% to 60 
0%. This study confirmed the observation that acute
yocarditis occurs frequently in the lateral epicardial region
f the LV and indicated that CMR may help guide EMB
ampling and increase the diagnostic yield of biopsy for
etecting myocarditis.
In 2005, Abdel-Aty et al. (58) reported 25 patients with
l regions with pathological findings in a patient with acute myocarditis.
ole (right), showing anterior hypokinesis (arrow) and a small pericardial
spin echo image showing regional edema of the anteroseptal, anterior,
t. (Lower row, left) T1-weighted fast spin echo images before (left) and
The quantitative evaluation showed a pathological signal change. (Lower
ned 5 min after application of gadolinium. There are extensive areas with
egions (arrows). A small artifact is noted, which should not be interpretedomica
d syst
hted
emen
rease.
obtaitrong clinical evidence for acute myocarditis and compared
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Noninvasive Imaging in Myocarditis November 21, 2006:2085–93ifferent approaches using T2-weighted (noncontrast) and
1-weighted, contrast-enhanced techniques. Global T2
ignal intensity and global early contrast enhancement were
igher in patients than in control subjects (p  0.001). The
alculated sensitivity, specificity, and diagnostic accuracy for
2 at a cutoff value of 1.9 were 84%, 74%, and 79%,
espectively. Interestingly, late gadolinium enhancement
LGE) had an excellent specificity (100%) but a low
ensitivity (44%), resulting in an overall diagnostic accuracy
f 71%. This may be because LGE may mainly reflect
rreversible injury. Accordingly, the combined use of differ-
nt CMR sequences may show a higher diagnostic accuracy
han single-technique protocols. Indeed, the investigators
ound that the best diagnostic performance was obtained if
ny 2 of the 3 criteria (threshold ratio for early enhancement
ignal intensity, ratio in T2 images, and presence of LGE)
ere used for making a diagnosis.
Recently, Laissy et al. (59) used early- and delayed-
erfusion CMR to differentiate acute myocarditis from
igure 3. Inversion-recovery prepared T1-weighted gradient echo images
Left) Short-axis view with “midwall sign” (arrows), which likely repr
our-chamber view with patchy late enhancement areas with predominanigure 4. Patient with edematous myocarditis, but lack of irreversible injury. (Le
egment. (Right) Late enhancement image with lack of high signal intensity arMI. Fifty-five patients with a clinical presentation sugges-
ive but not typical of AMI were prospectively examined.
verall, 31 patients had AMI confirmed by coronary
ngiography. The 24 myocarditis patients had normal cor-
nary angiography and resolution of clinical symptoms and
all motion abnormalities. A total of 96% of the myocar-
itis patients showed normal studies, whereas 100% of
atients with AMI had segmental distribution of subendo-
ardial defects (p  0.001) by first-pass perfusion imaging.
istributions were also significantly different (p  0.001)
n delayed enhancement. In AMI patients, delayed en-
ancement showed a smaller number of segmental vascular
istributions, whereas myocarditis patients usually had dif-
use or nodular (83%) patchy distribution in a nonsegmental
ascular distribution.
Wagner et al. (60) have provided the only study with
ong-term (30  4 months) follow-up on the prognostic
alue of CMR. This study confirmed a decrease in myocar-
ial enhancement over time in 16 acute myocarditis pa-
typical late enhancement patterns in a patient with chronic myocarditis.
fibrosis of the longitudinal myocardial fibers in the septum. (Right)
picardial, mainly lateral distribution (arrows).withft) T2-weighted image showing diffuse edema, mainly of the inferolateral
eas. LAX  long axis; SAX  short axis.
t
p
t
i
d
r
i
r
m
b
t
a
p
c
N
M
g
s
m
m
b
m
m
c
p
(
a
(
(
o
a
l
m
l
S
i
c
p
T
a
l
i
p
s
t
p
s
a
e
p
u
e
m
c
e
t
C
A
t
p
b
h
n
v
p
d
S
T
T
T
E
E
G
U
A
A
C
C
C
C
A
i
s
2091JACC Vol. 48, No. 10, 2006 Skouri et al.
November 21, 2006:2085–93 Noninvasive Imaging in Myocarditisients. In the same study, the investigators reported that a
ersisting elevated early enhancement obtained 4 weeks after
he onset of disease predicted reduced LV function and
ncreased LV size and symptoms after a follow-up of 3 years.
In summary, CMR is likely to become the standard
iagnostic test in suspected myocarditis and is widely
egarded as the most powerful noninvasive tool for diagnos-
ng myocarditis (61,62). Currently, there are no large-scale
andomized data on a successful specific therapy for viral
yocarditis. Several therapeutic approaches, however, are
eing studied, and substances will be available targeted
oward viruses or immunologic substrates. If these become
vailable, CMR may be a very efficient tool for selecting
atients for endomyocardial biopsies and subsequent spe-
ific therapy.
OVEL DIAGNOSTIC AND PROGNOSTIC MODALITIES
ost experimental data on myocarditis imaging have been
enerated from rodent models of transplant rejection. In-
ights from these studies are likely relevant to the study of
yocarditis because the underlying pathology is similar and
any of the mechanisms of inflammation are common to
oth disease processes. For example, intracellular adhesion
olecule (ICAM)-1 and to a lesser extent vascular adhesion
olecule–1 are expressed in acute myocarditis (63), and
ostimulatory molecules B7-1, B7-2, and CD-40 are ex-
ressed on cardiac myocytes in acute myocarditis and DCM
64). Weller et al. (65) detected acute transplant rejection in
rat model using myocardial contrast echocardiography
MCE) and ICAM-1-targeted microbubbles. Kondo et al.
66) also assessed the degree of rejection in a rodent model
f transplantation using leukocyte-targeted MCE. Riou et
l. (67) used leukocytes labeled with 99mTc-RP517 (a
eukotriene B4 receptor antagonist) in a canine model of
yocardial inflammation. Myocardial tracer uptake corre-
ated well with tissue myeloperoxidase staining by histology.
able 1. Comparison of the Sensitivity, Specificity, and Predictiv
Technique n
Sensitivity
(%)
roponin T 80 53
roponin I 88 34
MB-H 71 10–36
MB-IH 20 80
allium-67 scintigraphy 71 87
ltrasonic tissue characterization 106 100
MA vs. EMB-H 50 91–100
MA vs. EMB-IH 65 65
MR-T1 37 84
MR GE-T1 27 100
MR-IR-GRE 44 88
MR
T2/LGE/gRE 48 84/44/80
Any 2 76
MA  indium-antimyosin antibody scintigraphy; CMR  cardiac magnetic r
mmunohistochemical study; GE T1  gadolinium-enhanced T1-weighted; gRE  glob
equence; LGE  late gadolinium enhancement.imilar antigens may serve as cellular targets for molecular
maging in future studies of human myocarditis.
Similarly, a promising CMR method has used dextran-
oated ultrasmall superparamagnetic iron oxide (USPIO)
articles (68) to detect rodent transplant allograft rejection.
he USPIO particles are taken up mainly by macrophages
nd shorten relaxation times. In this study, macrophages
abeled with USPIO particles induced a significant decrease
n allograft MR signal intensity that correlated with the
athological rejection grade.
Apoptosis (programmed cell death) is commonly ob-
erved in myocarditis and transplant rejection (69). With
he onset of apoptosis, changes in the cell membrane
hospholipid composition are marked by the sudden expres-
ion of phosphatidylserine, a phospholipid that ordinarily
ppears on the inner leaflet of the cell membrane, on the
xternal leaflet of the membrane. Radiolabeled annexin-V, a
rotein with high affinity for phosphatidylserine, has been
sed to detect cells undergoing apoptosis in vivo. Tokita
t al. (70) and Peker et al. (71) showed in rat models of
yocarditis that 99mTc-annexin V uptake correlated
losely with sites of apoptosis. Narula et al. (72) and Kown
t al. (73) have also shown similar findings in cardiac
ransplantation patients during rejection episodes.
ONCLUSIONS
ccurate differentiation of acute inflammatory diseases of
he myocardium (e.g., myocarditis, sarcoidosis) from idio-
athic or genetic forms of DCM is clinically important
ecause their long-term outcomes differ. Myocarditis is
istologically characterized by varying degrees of myocardial
ecrosis, edema, apoptosis, and cellular infiltration. Nonin-
asive imaging techniques may hold the answer for selecting
atients who may benefit from biopsy and for better
efining the natural history of the disease via serial studies.
ensitivity and specificity play a crucial role in deciding on
ues of Laboratory and Imaging Techniques Used in Myocarditis
ecificity
(%)
Positive
Predictive
Value
Negative
Predictive
Value Reference(s)
96 93 56 74
89 — — 75
98 — — 10,11,38
85 — — 76
86 36 98 38
91 — — 29
31–44 28–33 93–100 63
71 86 41 77
100 — — 13
100 — — 54
91 — — 57
4/100/68 58
95.5 — —
ce imaging; EMB-H  endomyocardial biopsy-histological study; EMB-IH e Val
Sp
7
esonan
al (early) relative enhancement; IRGRE  inversion recovery gradient echo pulse
d
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ay be beneficial, especially in borderline cases (Table 1).
ntimyosin antibody imaging is useful (when available) for
etecting myocardial necrosis, an obligate component of
yocarditis. Tissue Doppler echocardiographic imaging is
xquisitely sensitive to myocardial contractile function and
eems helpful in detecting alterations associated with myo-
ardial inflammation and edema. CMR imaging is currently
he most accurate diagnostic method for both guiding
iopsy and following up disease activity over time. Annexin
imaging seems promising for detecting myocardial apo-
tosis and awaits future clinical trials. The ability to more
recisely and noninvasively assess myocardial inflammation,
ecrosis, and apoptosis should spur the evaluation of new
herapeutic strategies for the treatment of myocarditis and
nflammatory cardiomyopathies.
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ayo Clinic, 5 Gonda, 200 First Street SW, Rochester, Minne-
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